Bildquelle: NEUROtiker, Public domain, via Wikimedia Commons
Bildquelle: Durfo, CC BY-SA 3.0
Colchicine poisoning: the dark side of an ancient drug.
Clin Toxicol (Phila) 2010; 48: 407–414.
2.) Neogi T, Jansen T, Dalbeth N, et al.:
Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism Collaborative Initiative.
Arthritis Rheumatol 2015; 67: 2557–68.
3.) Engel B, Just J, Bleckwenn M, Weckbecker K:
Treatment options for gout.
Dtsch Arztebl Int 2017; 114: 215–22.
DOI: 10.3238/arztebl.2017.0215
4.) Krishnan E, Svendsen K, Neaton JD, Grandits G, Kuller LH:
Long-term cardiovascular mortality among middle-aged men with gout.
Arch Intern Med 2008; 168: 1104-10.
5.) Schumacher HR Jr, Becker MA, Wortmann RL, et al.:
Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
Arthritis Rheum 2008; 59: 1540-8.
6.) Becker MA, Schumacher HR Jr, Wortmann RL, et al.:
Febuxostat compared with allopurinol in patients with hyperuricemia and gout.
N Engl J Med 2005; 353: 2450-61.
7.) Schumacher HR Jr, Becker MA, Lloyd E, MacDonald PA, Lademacher C:
Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study.
Rheumatology (Oxford) 2009; 48: 188-94.
8.) White WB, et al. for the CARES Investigators:
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout.
N Engl J Med 2018;378:1200-10.
DOI: 10.1056/NEJMoa1710895
9.) Schmid JA, et al.:
Serum Uric Acid Concentrations in Meat Eaters, Fish Eaters, Vegetarians and Vegans: A Cross-Sectional Analysis in the EPIC-Oxford Cohort.
PLOS one https://doi.org/10.1371/journal.pone.0056339
10.) Klauser A, et al.:
Gout of hand and wrist: the value of US as compared with DECT.
European Radiology 2018;28:4174 – 4181
https://doi.org/10.1007/s00330-018-5363-9
Teil von
